Pulmonary Hypertension Institutional Registry at Hospital Italiano de Buenos Aires

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

200 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-01-01

Study Completion Date

2031-06-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to create a registry of patients with Pulmonary Hypertension who received medical care in the Hospital Italiano of Buenos Aires.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Pulmonary Hypertension in Patients Attending Sohag University Hospital: A Focus on The Etiology

NCT05207683

Patients With Pulmonary Hypertension

UNKNOWN

European Registry of Acutely Decompensated Pulmonary Arterial Hypertension

NCT06923917

Pulmonary Hypertension

NOT_YET_RECRUITING

American Registry of Ambulatory or Acutely Decompensated Heart Failure

NCT05295641

Heart Failure Acute Heart Failure (AHF) Chronic Heart Failure

COMPLETED

China National Heart Failure Registry

NCT02079428

Cardiac Failure Congestive Heart Failure

UNKNOWN

National Registry of Cardiovascular Surgery in Argentine

NCT05199116

Cardiovascular Diseases Surgery

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The Institutional Registry of Pulmonary Hypertension includes patients prospectively with incident pulmonary hypertension type I. It also includes prevalent cases from our HMO who had diagnosis prior the beginning of the registry.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hypertension, Pulmonary Arterial

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Diagnosed with PAH WHO group 1 (2022 ESC/ESR guidelines criteria) as the presence of a mean pulmonary artery pressure (mPAP) greater than 20 mmHg at rest with pulmonary arterial wedge pressure (PAWP) \>15 mmHg and pulmonary vascular resistance (PVR) \>2 WU, according to the 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension.
2. Included in the institutional registry of PAH of Hospital Italiano de Buenos Aires
3. Aged ≥18 years at the index date.

Minimum Eligible Age

17 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No